Guangdong Marubi Biotechnology Co (603983) - Total Assets
Based on the latest financial reports, Guangdong Marubi Biotechnology Co (603983) holds total assets worth CN¥4.69 Billion CNY (≈ $686.34 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Guangdong Marubi Biotechnology Co - Total Assets Trend (2011–2025)
This chart illustrates how Guangdong Marubi Biotechnology Co's total assets have evolved over time, based on quarterly financial data. Also see Guangdong Marubi Biotechnology Co stock valuation for the company's overall valuation and market capitalisation.
Guangdong Marubi Biotechnology Co - Asset Composition Analysis
Current Asset Composition (December 2025)
Guangdong Marubi Biotechnology Co's total assets of CN¥4.69 Billion consist of 48.5% current assets and 51.5% non-current assets. Review total liabilities of Guangdong Marubi Biotechnology Co to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 27.1% |
| Accounts Receivable | CN¥36.74 Million | 0.8% |
| Inventory | CN¥233.35 Million | 5.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥394.15 Million | 8.5% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Guangdong Marubi Biotechnology Co's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Guangdong Marubi Biotechnology Co share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangdong Marubi Biotechnology Co's current assets represent 48.5% of total assets in 2025, a decrease from 74.3% in 2011.
- Cash Position: Cash and equivalents constituted 27.1% of total assets in 2025, down from 60.9% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 2.0% in 2011.
- Asset Diversification: The largest asset category is intangible assets at 8.5% of total assets.
Guangdong Marubi Biotechnology Co Competitors by Total Assets
Key competitors of Guangdong Marubi Biotechnology Co based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Natura &Co Holding S.A.
SA:NTCO3
|
Brazil | R$34.86 Billion |
|
Hangzhou Haoyue Personal Care Co Ltd
SHG:605009
|
China | CN¥5.22 Billion |
|
PT Estee Gold Feet Tbk
JK:EURO
|
Indonesia | Rp57.96 Billion |
|
Kolmar Holding
KO:024720
|
Korea | ₩1.31 Trillion |
|
Able C&C
KO:078520
|
Korea | ₩144.48 Billion |
|
Englewood Lab Inc
KQ:950140
|
Korea | ₩230.10 Billion |
|
NFC Corporation
KQ:265740
|
Korea | ₩86.21 Billion |
|
Chungdamglobal Co. Ltd.
KQ:362320
|
Korea | ₩217.61 Billion |
Guangdong Marubi Biotechnology Co - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.97 | 2.24 | 3.49 |
| Quick Ratio | 1.77 | 2.03 | 3.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.14 Billion | CN¥1.46 Billion | CN¥1.94 Billion |
Guangdong Marubi Biotechnology Co - Advanced Valuation Insights
This section examines the relationship between Guangdong Marubi Biotechnology Co's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.53 |
| Latest Market Cap to Assets Ratio | 0.42 |
| Asset Growth Rate (YoY) | -8.9% |
| Total Assets | CN¥4.61 Billion |
| Market Capitalization | $1.95 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Guangdong Marubi Biotechnology Co's assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Guangdong Marubi Biotechnology Co's assets decreased by 8.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Guangdong Marubi Biotechnology Co (2011–2025)
The table below shows the annual total assets of Guangdong Marubi Biotechnology Co from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.61 Billion ≈ $675.09 Million |
-8.87% |
| 2024-12-31 | CN¥5.06 Billion ≈ $740.81 Million |
+13.67% |
| 2023-12-31 | CN¥4.45 Billion ≈ $651.72 Million |
+8.86% |
| 2022-12-31 | CN¥4.09 Billion ≈ $598.67 Million |
+8.76% |
| 2021-12-31 | CN¥3.76 Billion ≈ $550.45 Million |
-0.88% |
| 2020-12-31 | CN¥3.80 Billion ≈ $555.34 Million |
+10.44% |
| 2019-12-31 | CN¥3.44 Billion ≈ $502.84 Million |
+62.33% |
| 2018-12-31 | CN¥2.12 Billion ≈ $309.77 Million |
+32.06% |
| 2017-12-31 | CN¥1.60 Billion ≈ $234.56 Million |
+8.61% |
| 2016-12-31 | CN¥1.48 Billion ≈ $215.97 Million |
+8.06% |
| 2015-12-31 | CN¥1.37 Billion ≈ $199.86 Million |
+13.63% |
| 2014-12-31 | CN¥1.20 Billion ≈ $175.89 Million |
+27.97% |
| 2013-12-31 | CN¥939.25 Million ≈ $137.44 Million |
+33.29% |
| 2012-12-31 | CN¥704.69 Million ≈ $103.12 Million |
+18.05% |
| 2011-12-31 | CN¥596.96 Million ≈ $87.35 Million |
-- |
About Guangdong Marubi Biotechnology Co
Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company offers eye care, skincare, cleansing, and beauty and other products. It sells its products under the Marubi, Lianhuo, Chunji, and Passional Lover brands. The company was founded in 2002 and is based in Guangzhou, China.